In supersession of earlier intimation regarding Investor Presentation dated July 22, 2026, we hereby submit presentation on Un-audited Financial results for quarter ended June 30, 2026,

FY26 results: Standalone: Revenue 17.96bn +30% y-y (13.74bn FY25) EBITDA 3.14bn +74% y-y (1.80bn FY25) EBITDA margin 17.5% (13.1%) +440 bps y-y PAT 0.97bn (Normalised PAT) +197% y-y (0.33bn FY25) Consolidated: Revenue 17.96bn +30% y-y (13.74bn FY25) EBITDA 3.14bn +74% y-y (1.80bn FY25) EBITDA margin 17.5% (13.1%) +440 bps y-y PAT 0.97bn +197% y-y (0.33bn FY25) Q1FY27 results (unaudited): Standalone: Revenue 5.46bn +44% y-y (3.79bn Q1FY26) EBITDA 1.07bn +74% y-y (0.61bn Q1FY26) EBITDA margin 19.6% (16.2%) +340 bps y-y PAT 0.39bn +197% y-y (0.13bn Q1FY26) Consolidated: Revenue 5.46bn +44% y-y (3.79bn Q1FY26) EBITDA 1.07bn +74% y-y (0.61bn Q1FY26) EBITDA margin 19.6% (16.2%) +340 bps y-y PAT 0.39bn +197% y-y (0.13bn Q1FY26) Dividend: Not stated Commentary: Q1 FY27 performance shows strong sequential growth with fifth consecutive quarter of revenue, margin, PAT and RoCE expansion. 87% of FY27 revenue already contracted, reaffirming FY27 guidance of 28-30% revenue growth and 19-20% normalized EBITDA margin.